<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>20(2)</volume><submitter>Doering JE</submitter><funding>Moderna</funding><pubmed_abstract>Breast milk confers infants with immunity to a multitude of pathogens reflective of prior maternal infections and vaccinations. However, in outbreak situations where infants may be vulnerable to lethal infections due to gaps in the maternal immune repertoire, a case can be made for supplementing breast milk with one or more pathogen-specific monoclonal antibodies (mAbs) with known prophylactic or therapeutic activity. As oral delivery of recombinant IgG and IgA mAbs to infants has proven challenging, we investigated the use of mRNA-lipid nanoparticle (LNP) technology to stimulate pathogen-specific mAbs in milk. mRNA encoding the Vibrio cholerae O1 specific mAb, ZAC-3, as a human IgG1 or dimeric IgA2, was encapsulated in lipid nanoparticles (LNP) and administered parenterally to lactating a</pubmed_abstract><journal>PLoS neglected tropical diseases</journal><pagination>e0013518</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12919922</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Maternal expression and breast milk transfer of an mRNA- encoded monoclonal antibody in a murine model of cholera.</pubmed_title><pmcid>PMC12919922</pmcid><pubmed_authors>Plante O</pubmed_authors><pubmed_authors>Doering JE</pubmed_authors><pubmed_authors>Carfi A</pubmed_authors><pubmed_authors>Adewunmi Y</pubmed_authors><pubmed_authors>Mantis NJ</pubmed_authors><pubmed_authors>Deal CE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Maternal expression and breast milk transfer of an mRNA- encoded monoclonal antibody in a murine model of cholera.</name><description>Breast milk confers infants with immunity to a multitude of pathogens reflective of prior maternal infections and vaccinations. However, in outbreak situations where infants may be vulnerable to lethal infections due to gaps in the maternal immune repertoire, a case can be made for supplementing breast milk with one or more pathogen-specific monoclonal antibodies (mAbs) with known prophylactic or therapeutic activity. As oral delivery of recombinant IgG and IgA mAbs to infants has proven challenging, we investigated the use of mRNA-lipid nanoparticle (LNP) technology to stimulate pathogen-specific mAbs in milk. mRNA encoding the Vibrio cholerae O1 specific mAb, ZAC-3, as a human IgG1 or dimeric IgA2, was encapsulated in lipid nanoparticles (LNP) and administered parenterally to lactating a</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T09:24:24.593Z</modification><creation>2026-07-09T10:46:47.207Z</creation></dates><accession>S-EPMC12919922</accession><cross_references><pubmed>41662412</pubmed><doi>10.1371/journal.pntd.0013518</doi></cross_references></HashMap>